Does Aldosterone-to-Renin Ratio Predict the Antihypertensive Effect of the Aldosterone Antagonist Spironolactone? | Zendy

A MAHMUD | Zendy; Mohamed Mahgoub | Zendy; Megan Hall | Zendy; J. Feely | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Does Aldosterone-to-Renin Ratio Predict the Antihypertensive Effect of the Aldosterone Antagonist Spironolactone?

Author(s) -

A MAHMUD,

Mohamed Mahgoub,

Megan Hall,

J. Feely

Publication year - 2005

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1016/j.amjhyper.2005.06.010

Subject(s) - spironolactone , medicine , aldosterone , blood pressure , endocrinology , plasma renin activity , essential hypertension , diastole , population , renin–angiotensin system , environmental health

The recognition that some 10% to 15% of the hypertensive population may have aldosterone excess has increased the frequency of measurement of the aldosterone-to-renin ratio (ARR) and the use of aldosterone antagonists. Whether this ratio will predict the blood pressure (BP) response to spironolactone is not clear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research